STOCK TITAN

OrthoPediatrics Corp. Announces 1,000th Procedure Utilizing its Innovative Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”) System, the First Pediatric-Specific Solution Optimized to Treat Fractures and Deformities

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced the completion of its 1,000th surgery using the Pediatric Nailing Platform | FEMUR (PNP | FEMUR), a system designed for pediatric femur fracture treatment. This innovative intramedullary nailing system, which received FDA 510(k) clearance in 2018, addresses specific anatomical needs of children and adolescents. With a comprehensive range of sizes and instrumentation, the PNP system represents OrthoPediatrics' commitment to improving pediatric orthopedic solutions, building on nearly a decade of learning from its original PediNail system.

Positive
  • Achieved milestone of 1,000 surgeries using PNP | FEMUR, indicating strong adoption and efficacy.
  • PNP | FEMUR received FDA 510(k) clearance, validating its safety and effectiveness for pediatric use.
  • Comprehensive product offering with diverse sizes and options tailored for children and adolescents.
Negative
  • None.

WARSAW, Ind., Sept. 03, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced completion of the 1,000th surgery utilizing its Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”), the first system specifically designed and developed to address the unique pediatric anatomies when treating femoral fractures and deformity correction procedures.

PNP | FEMUR, which received FDA 510(k) clearance in 2018, is an intramedullary nailing system to stabilize fractures and deformity correction osteotomies. It features a full suite of innovative instrumentation offering two distinct child and adolescent implant options optimized to handle the unique needs of small stature trauma and deformity procedures. The system’s enhanced child sized nails range from 7-9mm and the new adolescent sized nails range from 9-12mm. The PNP system offers the widest range of nail and screw options coupled with unique size specific nail features implanted through proprietary instrumentation; providing a full spectrum, all-inclusive system to treat children of any age and size. 

“We are proud of the innovative solutions that evolved from an impressive engineering team working closely with world renowned physician advisors to solve unmet pediatric patient and surgical needs. The PNP|FEMUR is actually OP’s 2nd generation nailing system, which improved upon almost a decade of learnings from the original PediNail system. Being the first to design and launch a pediatric nailing system, we have an obligation to take those learnings and improve,” commented Joe Hauser, Vice President of OrthoPediatrics’ Trauma & Deformity Correction business. “The thousandth implant represents a great milestone for our company, the many children that have been treated, and their families. Also, it displays our never-ending dedication to improving our own pediatric implant systems.”

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact
The Ruth Group
Emma Poalillo
(646) 536-7024
epoalillo@theruthgroup.com


FAQ

What is the Pediatric Nailing Platform FEMUR by OrthoPediatrics?

The Pediatric Nailing Platform | FEMUR (PNP | FEMUR) is an intramedullary nailing system designed specifically for pediatric femur fracture treatment and deformity correction.

When did OrthoPediatrics complete its 1,000th surgery with PNP | FEMUR?

OrthoPediatrics completed its 1,000th surgery using the PNP | FEMUR on September 3, 2020.

What regulatory approval does the PNP | FEMUR have?

The PNP | FEMUR received FDA 510(k) clearance in 2018, ensuring its safety and effectiveness for pediatric use.

What is the significance of the 1,000th surgery milestone for KIDS (OrthoPediatrics)?

The 1,000th surgery milestone showcases the strong market acceptance of the PNP | FEMUR and reflects OrthoPediatrics' commitment to pediatric orthopedics.

What are the product offerings of OrthoPediatrics in pediatric orthopedics?

OrthoPediatrics offers 35 surgical systems addressing trauma, deformity, scoliosis, and other pediatric orthopedic procedures.

OrthoPediatrics Corp.

NASDAQ:KIDS

KIDS Rankings

KIDS Latest News

KIDS Stock Data

537.31M
16.34M
32.52%
71.08%
3.31%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
WARSAW